[go: up one dir, main page]

DE602005009819D1 - Verfahren zum nachweis von infektionen mit mykobakterien - Google Patents

Verfahren zum nachweis von infektionen mit mykobakterien

Info

Publication number
DE602005009819D1
DE602005009819D1 DE602005009819T DE602005009819T DE602005009819D1 DE 602005009819 D1 DE602005009819 D1 DE 602005009819D1 DE 602005009819 T DE602005009819 T DE 602005009819T DE 602005009819 T DE602005009819 T DE 602005009819T DE 602005009819 D1 DE602005009819 D1 DE 602005009819D1
Authority
DE
Germany
Prior art keywords
antigen
vessel
test
sample
mycolic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602005009819T
Other languages
English (en)
Inventor
Jan Adrianus Verschoor
Dismore Gilbert Siko
Wyngaardt Sandra Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pretoria
Original Assignee
University of Pretoria
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pretoria filed Critical University of Pretoria
Publication of DE602005009819D1 publication Critical patent/DE602005009819D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/5432—Liposomes or microcapsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE602005009819T 2004-05-13 2005-05-11 Verfahren zum nachweis von infektionen mit mykobakterien Expired - Fee Related DE602005009819D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200403678 2004-05-13
PCT/IB2005/051548 WO2005116654A1 (en) 2004-05-13 2005-05-11 A method for detecting mycobacterial infection

Publications (1)

Publication Number Publication Date
DE602005009819D1 true DE602005009819D1 (de) 2008-10-30

Family

ID=34967106

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005009819T Expired - Fee Related DE602005009819D1 (de) 2004-05-13 2005-05-11 Verfahren zum nachweis von infektionen mit mykobakterien

Country Status (7)

Country Link
US (1) US7851166B2 (de)
EP (1) EP1747463B1 (de)
JP (1) JP2007537438A (de)
AT (1) ATE408837T1 (de)
DE (1) DE602005009819D1 (de)
WO (1) WO2005116654A1 (de)
ZA (1) ZA200609113B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009066502A1 (ja) * 2007-11-20 2009-05-28 Konica Minolta Medical & Graphic, Inc. 固体支持体
PL2318837T4 (pl) 2008-07-11 2016-10-31 Wzmocniony czujnik testu immunologicznego
WO2012007903A2 (en) * 2010-07-15 2012-01-19 University Of Pretoria A method of detecting surrogate markers in a serum sample
GB201105436D0 (en) * 2011-03-31 2011-05-18 Univ Bangor Method
EP2859345B1 (de) * 2012-06-11 2017-07-26 University of Pretoria Liposomale zusammensetzung mit einem sterolmodifizierten lipid und einer gereinigten mykobakteriellen lipidzellwandkomponente sowie verwendung bei der diagnose von tuberkulose
HK1216441A1 (zh) 2013-05-16 2016-11-11 比勒陀利亚大学 诊断结核病的方法
US10197560B2 (en) 2013-06-27 2019-02-05 The Brigham And Women's Hospital, Inc. Methods and systems for determining M. tuberculosis infection
GB201414369D0 (en) * 2014-08-13 2014-09-24 Univ Bangor Kit and method
KR20170102344A (ko) 2015-01-05 2017-09-08 케이 인터네셔널 리미티드 활동성 결핵의 표시자를 검출하는 방법
WO2017077493A1 (en) 2015-11-06 2017-05-11 University Of Pretoria Core elements for point of care diagnosis of tuberculosis
US10337032B2 (en) 2016-02-01 2019-07-02 The University Of Manchester Compositions and methods for recombinant biosynthesis of propane
NL2016301B1 (en) * 2016-02-22 2017-08-25 Kei Int Ltd Method for detecting a marker for active tuberculosis.
NL2017204B1 (en) * 2016-06-08 2017-12-18 Kei International Ltd Solid substrate comprising antigens immobilised thereto, biosensor comprising said solid substrate and method for detecting the presence of mycobacterial material in a sample
WO2017211314A1 (en) 2016-06-08 2017-12-14 Kei International Limited Method for detecting presence of mycobacterial material in sample using immobilised mannosyl phosphoketide antigen
NL2021443B1 (en) 2018-08-08 2020-02-20 Kei International Ltd Synthetic antigens for tuberculosis detection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721109A (en) 1989-01-18 1998-02-24 Sawai Pharmaceutical Co., Ltd. Method for diagnosing infection caused by acid-fast bacterium
ATE187251T1 (de) * 1994-04-14 1999-12-15 Adcock Ingram Ltd Verfahren zum nachweis der gegenwart einer mykobakterien-spezies und testsatz sowie antikörpes zur verwendung in diesem verfahren

Also Published As

Publication number Publication date
EP1747463A1 (de) 2007-01-31
WO2005116654A1 (en) 2005-12-08
ATE408837T1 (de) 2008-10-15
ZA200609113B (en) 2008-07-30
EP1747463B1 (de) 2008-09-17
US7851166B2 (en) 2010-12-14
JP2007537438A (ja) 2007-12-20
US20090111125A1 (en) 2009-04-30

Similar Documents

Publication Publication Date Title
Zhang et al. Multiplex quantitative detection of SARS-CoV-2 specific IgG and IgM antibodies based on DNA-assisted nanopore sensing
WO2006126008A3 (en) Improved immunoassay methods
DE602005009819D1 (de) Verfahren zum nachweis von infektionen mit mykobakterien
JP2019530875A5 (de)
CY1126069T1 (el) Προσδιορισμος για αντισωματα ιου jc
MX2009004460A (es) Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos.
JP2019535015A5 (de)
NZ613646A (en) Elisa for vegf
JP2016528236A5 (de)
FR2935384B1 (fr) Procede de detection du virus de la rougeole, dispositif et kit utilisant ce procede
MX2013003161A (es) Dispositivos, metodos y kits de inmunocromatografia.
ATE466108T1 (de) Optoelektronisches detektionssystem
DE502005005132D1 (de) Verfahren zur erhöhung des dynamischen messbereichs von auf spezifischen bindereaktionen basierenden, insbesondere immunologischen testelementen
Tan et al. Rapid and quantitative detection of COVID-19 markers in micro-liter sized samples
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
JP2010530960A5 (de)
CN106461662B (zh) 肌酸激酶mb同工酶的测定方法以及其中使用的试剂盒
CN204287200U (zh) 尿微量白蛋白免疫层析定量检测试纸条
WO2007024735A3 (en) Method and antibodies for detecting nitrofuran
JP7216949B1 (ja) 等電点９．５以上のタンパク質の免疫測定方法及びそれに用いる検体希釈液、並びにイムノクロマトグラフィーキット
NZ334809A (en) Assay for the detection of antibodies against p53
EP4397681A4 (de) Antikörper, immobilisierte antikörper damit, antikörperzusammensetzung, reagens für immunologische messung, immunologisches messverfahren und verfahren zur verbesserung der antigenantwort von antikörpern
ATE519858T1 (de) Biologischer bodendetektor und verfahren zur verwendung davon
EA200700345A1 (ru) Обогащённое антитело для выявления микобактериальной инфекции, способы применения и диагностические тесты, применяющие такое антитело
CN114624195A (zh) 一种结合抗体的生物传感检测方法及检测系统

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee